Arrowhead Pharmaceuticals Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Arrowhead Pharmaceuticals's estimated annual revenue is currently $23.1M per year.
- Arrowhead Pharmaceuticals received $52.5M in venture funding in January 2018.
- Arrowhead Pharmaceuticals's estimated revenue per employee is $187,927
- Arrowhead Pharmaceuticals has 123 Employees.
- Arrowhead Pharmaceuticals grew their employee count by 12% last year.
- Arrowhead Pharmaceuticals currently has 23 job openings.
|Debbie Bell||Senior Director Safety Operations|
|Tao Pei||Senior Director of Chemistry|
|Diamond Martin||Associate Director, Clinical Operations|
|Dawn Christianson||Director of Program Management|
|Jane Davidson||Vice President, Administration|
|Caroline Laplaca||Executive Director Clinical Operations|
|Thomas Schluep||VP Program Management|
|Vincent Anzalone||Vice President, Finance and Investor Relations|
|Christine Wooddell||Director, Liver Targeting|
What Is Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Research and development activities are located in Madison, WI. Our R&D group includes fully-integrated capabilities for chemistry, biology, and toxicology. Madison is an exciting and sophisticated city that includes state government, the flagship campus of the University of Wisconsin, and major research organizations. Our HQ, clinical and regulatory operations are located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment and rich architectural setting.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|ZO Skin Health||$55.5M||295||2%||N/A|
Arrowhead Pharmaceuticals News
Arrowhead Pharmaceuticals Inc. ARWR, -1.04% jumped $1.44 to $34.36 on 1.18 million shares traded Wednesday. The company announced ...
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) business model of going after extrahepatic targets and establishing first mover advantage ...
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate ...
Arrowhead Pharmaceuticals Funding
|2016-08-10||$45.0M||Undisclosed||Cantor Fitzgerald & Co||Article|